NEXALIN TECHNOLOGY, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 31st, 2022 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • New York
Nexalin Technology, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of [●] units (the “Units”), with each Unit consisting of (a) one share of the Company’s common stock $0.001 par value per share (the “Common Stock”) and (b) one Warrant (the “Warrants”) to purchase one share of Common Stock, (the “Firm Units”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Option”) to purchase up to an additional [●] Units (the “Option Units”, and together with the Firm Units, the “Offered Securities”) on the terms set forth in Section 1(b) hereof. The offering of such Offered Securities is hereinafter called the “Offering”.
